share_log

Theratechnologies Announced It Has Entered Into An Agreement With Ionis Pharmaceuticals To License Two Investigational RNA-targeted Medicines Developed By Ionis

Theratechnologies Announced It Has Entered Into An Agreement With Ionis Pharmaceuticals To License Two Investigational RNA-targeted Medicines Developed By Ionis

Theratechnologies宣布已与ionis pharmaceuticals签署协议,以许可ionis开发的两种研究性RNA靶向药物。
Benzinga ·  12/04 20:40
Theratechnologies Announced It Has Entered Into An Agreement With Ionis Pharmaceuticals To License Two Investigational RNA-targeted Medicines Developed By Ionis
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发